Bashford CL, Menestrina G, Henkart PA, Pasternak CA. Cell damage by cytolysin. Spontaneous recovery and reversible inhibition by divalent cations. J Immunol 1988; 141: 3965–3974.
Hameed A, Olsen KJ, Lee M-K, Lichtenheld MG, Podack ER. Cytolysis by Capermeable transmembrane channels. Pore formation causes extensive DNA degradation and cell lysis. J Exp Med 1989; 169: 765–777.
Podack ER, Dennert G. Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature 1983; 302: 442–445.
Henkart PA, Millard PJ, Reynolds CW, Henkart MP. Cytolytic activity of purified cytoplasmic granules from cytotoxic rat large granular lymphocyte tumors. J Exp Med 1984; 160: 75–93.
Millard PJ, Henkart MP, Reynolds CW, Henkart PA. Purification and properties of cytoplasmic granules from cytotoxic rat LGL tumors. J Immunol 1984; 132: 3197–3204.
Berke G. The CTL's kiss of death. Cell 1995; 81: 9–12.
Henkart PA, Williams MS, Zacharchuk CM, Sarin A. Do CTL kill target cells by inducing apoptosis? Semin Immunol 1997; 9: 135–144.
Russell JH, Ley TJ. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002; 20: 323–370.
Ashkenazi A, Dixit V. Apoptosis control by death and decoy receptors. Curr Opin Cell Biol 1999; 11: 255–260.
Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998; 281: 1305–1308.
Trapani JA, Smyth MJ. Functional significance of the perforin/ granzyme cell death pathway. Nat Rev Immunol 2002; 2: 735–747.
Shi L, Mai S, Israels S, et al. Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization. J Exp Med 1997; 185: 855–866.
Kam C-M, Hudig D, Powers JC. Granzymes (lymphocyte serine proteases): Characterization with natural and synthetic substrates and inhibitors. Biochem Biophys Acta 2000; 1477: 307–323.
Edwards KM, Davis JE, Browne KA, Sutton VR, Trapani JA. Anti-viral strategies of cytotoxic T lymphocytes are manifested through a variety of granule-bound pathways of apoptosis induction. Immunol and Cell Biol 1999; 77.
Trapani JA. Dual mechanisms of apoptosis induction by cytotoxic lymphocytes. Int Rev Cytol 1998; 182: 111–192.
Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994; 76: 977–987.
Shi L, Kam CM, Powers JC, Aebersold R, Greenberg AH. Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med 1992; 176: 1521–1529.
Trapani JA, Jans P, Smyth MJ, et al. Perforin-dependent nuclear entry of granzyme B precedes apoptosis, and is not a consequence of nuclear membrane dysfunction. Cell Death Different 1998; 5: 488–496.
Beresford PJ, Xia Z, Greenberg AH, Lieberman J. Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation. Immunity 1999; 10: 585–594.
Shresta S, Graubert TA, Thomas DA, Raptis SZ, Ley TJ. Granzyme A initiates an alternative pathway for granule-mediated apoptosis. Immunity 1999; 10: 595–405.
Sutton VR, Vaux DL, Trapani JA. Bcl-2 prevents apoptosis induced by perforin and granzyme B, but not that mediated by whole cytotoxic lymphocytes. J Immunol 1997; 158: 5783–5790.
Green DR, Reed JC. Mitochondria and apoptosis. Science 1998; 281: 1309–1312.
Barry M, Heibein JA, Pinkoski MJ, et al. Granyzme b short-circuits the need for caspase 8 activity during granule-mediated cytotoxic T-lymphocyte killing by directly cleaving bid. Mol Cell Biol 2000; 20: 3781–3794.
Heibein JA, Goping IS, Barry M, et al. Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members Bid and Bax. J Exp Med 2000; 192: 1391–1401.
Sutton VR, Davis JE, Cancilla M, et al. Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation. J Exp Med 2000; 192: 1403–1413.
Sutton VR, Wowk ME, Cancilla M, Trapani JA. Caspase activation by granzyme B is indirect, and caspase autoprocessing requires the release of proapoptotic mitochondrial factors. Immunity 2003; 18: 319–329.
Li P, Nijihawan D, Budihardjo I, et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479–489.
Goping IS, Barry M, Liston P, et al. Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition. Immunity 2003; 18: 355–365.
Duband-Goulet I, Courvalin JC, Buendia B. LBR, a chromatin and lamin binding protein from the inner nuclear membrane, is proteolyzed at late stages of apoptosis. J Cell Sci 1998; 111: 1441–1451.
Sakahira H, Enari M, Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 1998; 391: 96–99.
Enari M, Sakahira H, Yokoyama H, et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 1998; 391: 43–50.
Liu X, Zou H, Slaughter C, Wang X. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 1997; 89: 175–184.
Brunner KT, Mauel J, Cerottini J-C, Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells of 51Cr labeled allogenic target cells in vitro: Inhibition by isoantibody and by drugs. Immunology 1968; 14: 181–196.
Lichtenfels R, Biddison WE, Schulz H, Vogt AB, Martin R. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J Immunol Methods 1994; 172: 227–239.
Wierda WG, Mehr DS, Kim YB. Comparison of fluorochrome-labeled and 51Cr-labeled targets for natural killer cytotoxicity assay. J Immunol Methods 1989; 122: 15–24.
Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983; 64: 313–320.
Szekeres J, Pacsa AS, Pejtsik B. Measurement of lymphocyte cytotoxicity by assessing endogenous alkaline phosphatase activity of the target cells. J Immunol Methods 1981; 40: 151–154.
Schafer H, Schafer A, Kiderlen AF, Masihi KN, Burger R. A highly sensitive cytotoxicity assay based on the release of reporter enzymes, from stably transfected cell lines. J Immunol Methods 1997; 204: 89–98.
Bachy M, Bonnin-Rivalland A, Tilliet V, Trannoy E. Beta galactosidase release as an alternative to chromium release in cytotoxic T-cell assays. J Immunol Methods 1999; 230: 37–46.
Sheehy ME, McDermott AB, Furlan SN, Klenerman P, Nixon DF. A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. J Immunol Methods 2001; 249: 99–110.
Lecoeur H, Fevrier M, Garcia S, Riviere Y, Gougeon ML. A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J Immunol Methods 2001; 253: 177–187.
Sanderson CJ, Taylor GA. The kinetics of Cr release from target cells in cell mediated cytotoxicity and the relationship to the kinetics of killing. Cell Tissue Kinet 1975; 8: 23–32.
Shiver JW, Henkart PA. A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin/perforin gene. Cell 1991; 64: 1175–1181.
Shiver JW, Su L, Henkart PA. Cytotoxicity with target DNA breakdown by rat basophilic leukemia cells expressing both cytolysin and granzyme A. Cell 1992; 71: 315–322.
Davis JE, Sutton VR, Smyth MJ, Trapani JA. Dependence of granzyme B-mediated cell death on a pathway regulated by Bcl-2 or its viral homolog, BHRF1. Cell Death Differ 2000; 7: 973–983.
Jagarlamoody SM, Aust JC, Tew RH, McKhann CF. In vitro detection of cytotoxic cellular immunity against tumor-specific antigens by a radioisotopic technique. Proc Natl Acad Sci USA 1971; 68: 1346–1350.
Cohen AM, Burdick JF, Ketcham AS. Cell-mediated cytotoxicity: An assay using 125 I-iododeoxyuridine-labeled target cells. J Immunol 1971; 107: 895–898.
Le Mevel BP, Oldham RK, Wells SA, Herberman RB. An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: Kinetics of incorporation and toxicity. J Natl Cancer Inst 1973; 51: 1551–1558.
Oldham RK, Siwarski D, McCoy JL, Plata EJ, Herberman RB. Evaluation of a cell-mediated cytotoxicity assay utilizing 125 iododeoxyuridine-labeled tissue-culture target cells. Natl Cancer Inst Monogr 1973; 37: 49–58.
Munger WE, Berrebi GA, Henkart PA. Possible involvement of CTL granule proteases in target cell DNA breakdown. Immunol Rev 1988; 103: 99–109.
Matzinger P. The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 1991; 145: 185–192.
Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9: 459–470.
Walker PR, Saas P, Dietrich PY. Role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back. J Immunol 1997; 158: 4521–4524.
Dong H, Strome SE, Salomao DR, et al. Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion. Nat Med 2002; 8: 793–800.
Trambas CM, Griffiths GM. Delivering the kiss of death. Nature Immunology 2003; 4: 399–403.
Liu L, Chahroudi A, Silvestri G, et al. Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nature Med 2002; 8: 185–189.
Brickner AG, Warren EH, Caldwell JA, et al. The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J Exp Med 2001; 193: 195–206.
Kataoka T, Shinohara N, Takayama H, et al. Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin-and Fas-based lytic pathways in cell-mediated cytotoxicity. J Immunol 1996; 156: 3678–3686.
Goyal L. Cell death inhibition: Keeping caspases in check. Cell 2001; 104: 805–808.
Cheng EH, Wei MC, Weiler S, et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX-and BAK-mediated mitochondrial apoptosis. Mol Cell 2001; 8: 705–711.
Waterhouse NJ, Trapani JA. CTL: Caspases Terminate Life, but that's not the whole story. Tissue Antigens 2002; 59: 175–183.
Bernardi P, Petronilli V, Di Lisa F, Forte M. A mitochondrial perspective on cell death. Trends Biochem Sci 2001; 26: 112–117.